|
Pulmonology
Alterations in lung and gut microbiota reduce diversity in patients with nontuberculous mycobacterial pulmonary disease
Ji Yeon Choi, Bora Shim, Youngmok Park, Young Ae Kang
Korean J Intern Med. 2023;38(6):879-892. Published online October 23, 2023
Background/Aims: Although the incidence of nontuberculous mycobacteria pulmonary disease (NTM-PD), a chronic infectious disease, is increasing, lung and gut microbiota dysbiosis in NTM patients has rarely been studied and was therefore the focus of this study.
Methods: We analyzed the microbiota di..
|
|
|
Gastroenterology
Recognition and attitudes of Korean physicians toward fecal microbiota transplantation: a survey study
Tae-Geun Gweon, Yoo Jin Lee, Sung Kyun Yim, Seung Yong Kim, Chang Hwan Choi, Young-Seok Cho; on behalf of the Microbiome Research Group of the Korean Society for Neurogastroenterology and Motility
Korean J Intern Med. 2023;38(1):48-55. Published online November 10, 2022
Background/Aims: Fecal microbiota transplantation (FMT) represents a treatment option for recurrent Clostridioides difficile infection (CDI). Recently, FMT has been investigated in various clinical settings other than CDI. This study examined Korean physicians’ recognition of FMT and their attitude..
|
|
|
Analysis of the gut microbiome using extracellular vesicles in the urine of patients with colorectal cancer
Hyuk Yoon, Nam-Eun Kim, Jihye Park, Cheol Min Shin, Nayoung Kim, Dong Ho Lee, Jae Yong Park, Chang Hwan Choi, Jae Gyu Kim, Young Soo Park
Korean J Intern Med. 2023;38(1):27-38. Published online November 10, 2022
Background/Aims: We evaluated the gut microbiome using extracellular vesicles (EVs) in the urine of patients with colorectal cancer (CRC) to determine whether gut-microbe-derived EVs could be a potential biomarker for the diagnosis of CRC.
Methods: EVs were isolated from the urine of patients with ..
|
|
|
Diet, microbiota, and inflammatory bowel disease: lessons from Japanese foods
Takanori Kanai, Katsuyoshi Matsuoka, Makoto Naganuma, Atsushi Hayashi, Tadakazu Hisamatsu
Korean J Intern Med. 2014;29(4):409-415. Published online June 27, 2014
The incidence and prevalence of inflammatory bowel diseases (IBDs) including ulcerative colitis and Crohn disease are rapidly increasing in Western countries and in developed Asian countries. Although biologic agents targeting the immune system have been effective in patients with IBD, cessation of ..
|
|
|
